Supportive Care
Supportive Care is a topic covered in the Washington Manual of Medical Therapeutics.
To view the entire topic, please log in or purchase a subscription.
The Washington Manual is an award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Explore these free sample topics:
-- The first section of this topic is shown below --
Nausea and Vomiting
- If nausea/vomiting occurs, chemotherapy-induced nausea and vomiting (CINV), as well as alternative etiologies such as bowel obstruction, brain metastasis, constipation and gastroenteritis, should be considered.
- CINV can be categorized as acute (<24 hours) or delayed (>24 hours). Acute CINV is an important predictor of delayed CINV.
- Commonly used antiemetic medications for prevention and management of CINV include dexamethasone, 5-hydroxytryptamine-3 (5-HT3) receptor antagonists (ondansetron, granisetron, dolasetron, palonosetron), neurokinin-1 receptor antagonists (aprepitant, fosaprepitant, etc.), prochlorperazine, anxiolytics (lorazepam), and olanzapine (atypical antipsychotic).
-- To view the remaining sections of this topic, please log in or purchase a subscription --
Nausea and Vomiting
- If nausea/vomiting occurs, chemotherapy-induced nausea and vomiting (CINV), as well as alternative etiologies such as bowel obstruction, brain metastasis, constipation and gastroenteritis, should be considered.
- CINV can be categorized as acute (<24 hours) or delayed (>24 hours). Acute CINV is an important predictor of delayed CINV.
- Commonly used antiemetic medications for prevention and management of CINV include dexamethasone, 5-hydroxytryptamine-3 (5-HT3) receptor antagonists (ondansetron, granisetron, dolasetron, palonosetron), neurokinin-1 receptor antagonists (aprepitant, fosaprepitant, etc.), prochlorperazine, anxiolytics (lorazepam), and olanzapine (atypical antipsychotic).
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Bhat, Pavat, et al., editors. "Supportive Care." Washington Manual of Medical Therapeutics, 35th ed., Wolters Kluwer Health, 2016. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602872/all/Supportive_Care.
Supportive Care. In: Bhat PP, Dretler AA, Gdowski MM, et al, eds. Washington Manual of Medical Therapeutics. Wolters Kluwer Health; 2016. https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602872/all/Supportive_Care. Accessed February 8, 2023.
Supportive Care. (2016). In Bhat, P., Dretler, A., Gdowski, M., Ramgopal, R., & Williams, D. (Eds.), Washington Manual of Medical Therapeutics (35th ed.). Wolters Kluwer Health. https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602872/all/Supportive_Care
Supportive Care [Internet]. In: Bhat PP, Dretler AA, Gdowski MM, Ramgopal RR, Williams DD, editors. Washington Manual of Medical Therapeutics. Wolters Kluwer Health; 2016. [cited 2023 February 08]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602872/all/Supportive_Care.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Supportive Care
ID - 602872
ED - Williams,Dominique,
ED - Bhat,Pavat,
ED - Dretler,Alexandra,
ED - Gdowski,Mark,
ED - Ramgopal,Rajeev,
BT - Washington Manual of Medical Therapeutics
UR - https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602872/all/Supportive_Care
PB - Wolters Kluwer Health
ET - 35
DB - The Washington Manual
DP - Unbound Medicine
ER -